8-Chloro-11-(4-methyl-piperazin-1-yl)-dibenzo[b,f][1,4]thiazepine (isoclothiapine)

ID: ALA67284

Cas Number: 5747-55-7

PubChem CID: 9928073

Max Phase: Preclinical

Molecular Formula: C18H18ClN3S

Molecular Weight: 343.88

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(C2=Nc3cc(Cl)ccc3Sc3ccccc32)CC1

Standard InChI:  InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-4-2-3-5-16(14)23-17-7-6-13(19)12-15(17)20-18/h2-7,12H,8-11H2,1H3

Standard InChI Key:  KPQVFXHERXUYEX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    3.5328  -22.1253    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.1816  -21.2797    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3667  -22.0837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6726  -21.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4234  -20.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4588  -20.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7442  -19.6392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9923  -20.0357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9606  -20.8785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8354  -22.7504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0419  -22.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6497  -23.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0498  -24.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8464  -24.1191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2350  -23.4308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1904  -22.0818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6027  -22.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4228  -22.7961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8368  -22.0836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4246  -21.3694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5983  -21.3676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6633  -22.0848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7774  -18.8133    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 10 11  2  0
  4  5  2  0
 11 12  1  0
  5  2  1  0
 12 13  2  0
  5  6  1  0
 13 14  1  0
  3 10  1  0
 14 15  2  0
 15 10  1  0
  6  7  2  0
  3 16  1  0
 16 17  1  0
 11  1  1  0
  7  8  1  0
  2  3  2  0
  8  9  2  0
  9  4  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
  4  1  1  0
  7 23  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

HRH4 Tchem Histamine H4 receptor (3997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine D1 receptor (1900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2b Serotonin 2 (5-HT2) receptor (2078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine receptors; D1 & D2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.88Molecular Weight (Monoisotopic): 343.0910AlogP: 4.13#Rotatable Bonds:
Polar Surface Area: 18.84Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.27CX LogP: 4.15CX LogD: 3.91
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -1.09

References

1. Liégeois JF, Bruhwyler J, Damas J, Nguyen TP, Chleide EM, Mercier MG, Rogister FA, Delarge JE..  (1993)  New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study.,  36  (15): [PMID:8101877] [10.1021/jm00067a009]
2. Warawa EJ, Migler BM, Ohnmacht CJ, Needles AL, Gatos GC, McLaren FM, Nelson CL, Kirkland KM..  (2001)  Behavioral approach to nondyskinetic dopamine antagonists: identification of seroquel.,  44  (3): [PMID:11462978] [10.1021/jm000242+]
3. Liégeois JF, Rogister FA, Bruhwyler J, Damas J, Nguyen TP, Inarejos MO, Chleide EM, Mercier MG, Delarge JE..  (1994)  Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.,  37  (4): [PMID:7907148] [10.1021/jm00030a011]
4. Smits RA, Lim HD, Stegink B, Bakker RA, de Esch IJ, Leurs R..  (2006)  Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,  49  (15): [PMID:16854056] [10.1021/jm051008s]
5. Vischer HF, Hulshof JW, Hulscher S, Fratantoni SA, Verheij MH, Victorina J, Smit MJ, de Esch IJ, Leurs R..  (2010)  Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28.,  18  (2): [PMID:20031418] [10.1016/j.bmc.2009.11.060]

Source